Cell Reports (Jan 2015)

Accelerating Novel Candidate Gene Discovery in Neurogenetic Disorders via Whole-Exome Sequencing of Prescreened Multiplex Consanguineous Families

  • Anas M. Alazami,
  • Nisha Patel,
  • Hanan E. Shamseldin,
  • Shamsa Anazi,
  • Mohammed S. Al-Dosari,
  • Fatema Alzahrani,
  • Hadia Hijazi,
  • Muneera Alshammari,
  • Mohammed A. Aldahmesh,
  • Mustafa A. Salih,
  • Eissa Faqeih,
  • Amal Alhashem,
  • Fahad A. Bashiri,
  • Mohammed Al-Owain,
  • Amal Y. Kentab,
  • Sameera Sogaty,
  • Saeed Al Tala,
  • Mohamad-Hani Temsah,
  • Maha Tulbah,
  • Rasha F. Aljelaify,
  • Saad A. Alshahwan,
  • Mohammed Zain Seidahmed,
  • Adnan A. Alhadid,
  • Hesham Aldhalaan,
  • Fatema AlQallaf,
  • Wesam Kurdi,
  • Majid Alfadhel,
  • Zainab Babay,
  • Mohammad Alsogheer,
  • Namik Kaya,
  • Zuhair N. Al-Hassnan,
  • Ghada M.H. Abdel-Salam,
  • Nouriya Al-Sannaa,
  • Fuad Al Mutairi,
  • Heba Y. El Khashab,
  • Saeed Bohlega,
  • Xiaofei Jia,
  • Henry C. Nguyen,
  • Rakad Hammami,
  • Nouran Adly,
  • Jawahir Y. Mohamed,
  • Firdous Abdulwahab,
  • Niema Ibrahim,
  • Ewa A. Naim,
  • Banan Al-Younes,
  • Brian F. Meyer,
  • Mais Hashem,
  • Ranad Shaheen,
  • Yong Xiong,
  • Mohamed Abouelhoda,
  • Abdulrahman A. Aldeeri,
  • Dorota M. Monies,
  • Fowzan S. Alkuraya

DOI
https://doi.org/10.1016/j.celrep.2014.12.015
Journal volume & issue
Vol. 10, no. 2
pp. 148 – 161

Abstract

Read online

Our knowledge of disease genes in neurological disorders is incomplete. With the aim of closing this gap, we performed whole-exome sequencing on 143 multiplex consanguineous families in whom known disease genes had been excluded by autozygosity mapping and candidate gene analysis. This prescreening step led to the identification of 69 recessive genes not previously associated with disease, of which 33 are here described (SPDL1, TUBA3E, INO80, NID1, TSEN15, DMBX1, CLHC1, C12orf4, WDR93, ST7, MATN4, SEC24D, PCDHB4, PTPN23, TAF6, TBCK, FAM177A1, KIAA1109, MTSS1L, XIRP1, KCTD3, CHAF1B, ARV1, ISCA2, PTRH2, GEMIN4, MYOCD, PDPR, DPH1, NUP107, TMEM92, EPB41L4A, and FAM120AOS). We also encountered instances in which the phenotype departed significantly from the established clinical presentation of a known disease gene. Overall, a likely causal mutation was identified in >73% of our cases. This study contributes to the global effort toward a full compendium of disease genes affecting brain function.